vs
Side-by-side financial comparison of MOBIX LABS, INC (MOBX) and PAVmed Inc. (PAVM). Click either name above to swap in a different company.
MOBIX LABS, INC is the larger business by last-quarter revenue ($1.9M vs $996.0K, roughly 1.9× PAVmed Inc.). PAVmed Inc. runs the higher net margin — 6465.8% vs -540.0%, a 7005.8% gap on every dollar of revenue. On growth, PAVmed Inc. posted the faster year-over-year revenue change (25.9% vs -40.8%).
PAVmed Inc. is a commercial-stage medical technology company that designs, develops and commercializes innovative diagnostic and therapeutic medical products. Its portfolio covers point-of-care diagnostics, interventional oncology and gastroenterology solutions, primarily serving healthcare providers and patients across the United States.
MOBX vs PAVM — Head-to-Head
Income Statement — Q1 FY2026 vs Q3 FY2024
| Metric | | |
|---|---|---|
| Revenue | $1.9M | $996.0K |
| Net Profit | $-10.1M | $64.4M |
| Gross Margin | 31.0% | -38.7% |
| Operating Margin | -471.1% | -1162.4% |
| Net Margin | -540.0% | 6465.8% |
| Revenue YoY | -40.8% | 25.9% |
| Net Profit YoY | 49.0% | 464.4% |
| EPS (diluted) | $-0.16 | $1.44 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $1.9M | — | ||
| Q3 25 | $1.9M | — | ||
| Q2 25 | $2.4M | — | ||
| Q1 25 | $2.5M | — | ||
| Q4 24 | $3.2M | — | ||
| Q3 24 | $3.0M | $996.0K | ||
| Q2 24 | $2.1M | $979.0K | ||
| Q1 24 | $1.1M | $1.0M |
| Q4 25 | $-10.1M | — | ||
| Q3 25 | $-15.7M | — | ||
| Q2 25 | $-8.3M | — | ||
| Q1 25 | $-2.3M | — | ||
| Q4 24 | $-19.8M | — | ||
| Q3 24 | $-11.5M | $64.4M | ||
| Q2 24 | $-7.7M | $-10.8M | ||
| Q1 24 | $-1.8M | $-15.2M |
| Q4 25 | 31.0% | — | ||
| Q3 25 | 50.5% | — | ||
| Q2 25 | 57.4% | — | ||
| Q1 25 | 40.6% | — | ||
| Q4 24 | 53.2% | — | ||
| Q3 24 | 56.6% | -38.7% | ||
| Q2 24 | 35.5% | -70.2% | ||
| Q1 24 | 16.9% | -72.7% |
| Q4 25 | -471.1% | — | ||
| Q3 25 | -834.9% | — | ||
| Q2 25 | -343.4% | — | ||
| Q1 25 | -311.7% | — | ||
| Q4 24 | -461.7% | — | ||
| Q3 24 | -378.0% | -1162.4% | ||
| Q2 24 | -454.2% | -1397.8% | ||
| Q1 24 | -747.8% | -1389.7% |
| Q4 25 | -540.0% | — | ||
| Q3 25 | -835.8% | — | ||
| Q2 25 | -352.0% | — | ||
| Q1 25 | -91.2% | — | ||
| Q4 24 | -626.0% | — | ||
| Q3 24 | -390.6% | 6465.8% | ||
| Q2 24 | -373.1% | -1105.9% | ||
| Q1 24 | -153.1% | -1506.1% |
| Q4 25 | $-0.16 | — | ||
| Q3 25 | $-0.26 | — | ||
| Q2 25 | $-0.17 | — | ||
| Q1 25 | $-0.06 | — | ||
| Q4 24 | $-0.52 | — | ||
| Q3 24 | $-0.33 | $1.44 | ||
| Q2 24 | $-0.25 | $-1.19 | ||
| Q1 24 | $-0.21 | $-2.62 |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | — | $765.0K |
| Total DebtLower is stronger | $6.3M | — |
| Stockholders' EquityBook value | $4.7M | $-4.9M |
| Total Assets | $32.7M | $30.6M |
| Debt / EquityLower = less leverage | 1.34× | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | $765.0K | ||
| Q2 24 | — | $25.5M | ||
| Q1 24 | — | $25.5M |
| Q4 25 | $6.3M | — | ||
| Q3 25 | $6.2M | — | ||
| Q2 25 | $4.4M | — | ||
| Q1 25 | $4.6M | — | ||
| Q4 24 | $3.6M | — | ||
| Q3 24 | $3.4M | — | ||
| Q2 24 | $3.2M | — | ||
| Q1 24 | $3.2M | — |
| Q4 25 | $4.7M | — | ||
| Q3 25 | $-336.0K | — | ||
| Q2 25 | $425.0K | — | ||
| Q1 25 | $342.0K | — | ||
| Q4 24 | $-3.0M | — | ||
| Q3 24 | $5.5M | $-4.9M | ||
| Q2 24 | $8.5M | $-73.9M | ||
| Q1 24 | $4.2M | $-68.8M |
| Q4 25 | $32.7M | — | ||
| Q3 25 | $37.1M | — | ||
| Q2 25 | $34.6M | — | ||
| Q1 25 | $36.5M | — | ||
| Q4 24 | $37.3M | — | ||
| Q3 24 | $39.1M | $30.6M | ||
| Q2 24 | $41.3M | $39.4M | ||
| Q1 24 | $29.5M | $37.3M |
| Q4 25 | 1.34× | — | ||
| Q3 25 | — | — | ||
| Q2 25 | 10.26× | — | ||
| Q1 25 | 13.44× | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 0.62× | — | ||
| Q2 24 | 0.38× | — | ||
| Q1 24 | 0.76× | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-4.8M | $-8.9M |
| Free Cash FlowOCF − Capex | — | $-8.9M |
| FCF MarginFCF / Revenue | — | -892.5% |
| Capex IntensityCapex / Revenue | — | 0.6% |
| Cash ConversionOCF / Net Profit | — | -0.14× |
| TTM Free Cash FlowTrailing 4 quarters | — | $-45.8M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-4.8M | — | ||
| Q3 25 | $-4.5M | — | ||
| Q2 25 | $-4.1M | — | ||
| Q1 25 | $-586.0K | — | ||
| Q4 24 | $-930.0K | — | ||
| Q3 24 | $-3.6M | $-8.9M | ||
| Q2 24 | $-3.1M | $-11.7M | ||
| Q1 24 | $-8.1M | $-13.1M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | $-4.6M | $-8.9M | ||
| Q2 24 | $-3.1M | $-11.7M | ||
| Q1 24 | $-9.1M | $-13.2M |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | -157.1% | -892.5% | ||
| Q2 24 | -151.8% | -1190.9% | ||
| Q1 24 | -794.1% | -1302.1% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | 34.5% | 0.6% | ||
| Q2 24 | 2.2% | 0.3% | ||
| Q1 24 | 87.3% | 4.2% |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | — | ||
| Q4 24 | — | — | ||
| Q3 24 | — | -0.14× | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
Revenue Breakdown by Segment
MOBX
| US | $1.7M | 92% |
| Other | $155.0K | 8% |
PAVM
Segment breakdown not available.
